1. Home
  2. HSDT vs SNTG Comparison

HSDT vs SNTG Comparison

Compare HSDT & SNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSDT
  • SNTG
  • Stock Information
  • Founded
  • HSDT N/A
  • SNTG 2009
  • Country
  • HSDT United States
  • SNTG China
  • Employees
  • HSDT 21
  • SNTG N/A
  • Industry
  • HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SNTG Finance: Consumer Services
  • Sector
  • HSDT Health Care
  • SNTG Finance
  • Exchange
  • HSDT Nasdaq
  • SNTG Nasdaq
  • Market Cap
  • HSDT 6.4M
  • SNTG 4.8M
  • IPO Year
  • HSDT N/A
  • SNTG 2021
  • Fundamental
  • Price
  • HSDT $6.00
  • SNTG $2.02
  • Analyst Decision
  • HSDT Hold
  • SNTG
  • Analyst Count
  • HSDT 1
  • SNTG 0
  • Target Price
  • HSDT N/A
  • SNTG N/A
  • AVG Volume (30 Days)
  • HSDT 27.8K
  • SNTG 423.9K
  • Earning Date
  • HSDT 08-14-2025
  • SNTG 05-14-2025
  • Dividend Yield
  • HSDT N/A
  • SNTG N/A
  • EPS Growth
  • HSDT N/A
  • SNTG N/A
  • EPS
  • HSDT N/A
  • SNTG N/A
  • Revenue
  • HSDT $295,000.00
  • SNTG $107,507.00
  • Revenue This Year
  • HSDT N/A
  • SNTG N/A
  • Revenue Next Year
  • HSDT $75.13
  • SNTG N/A
  • P/E Ratio
  • HSDT N/A
  • SNTG N/A
  • Revenue Growth
  • HSDT N/A
  • SNTG N/A
  • 52 Week Low
  • HSDT $5.37
  • SNTG $1.43
  • 52 Week High
  • HSDT $1,200.00
  • SNTG $3.52
  • Technical
  • Relative Strength Index (RSI)
  • HSDT 28.43
  • SNTG 57.09
  • Support Level
  • HSDT $5.81
  • SNTG $1.60
  • Resistance Level
  • HSDT $6.57
  • SNTG $3.32
  • Average True Range (ATR)
  • HSDT 0.34
  • SNTG 0.20
  • MACD
  • HSDT 0.84
  • SNTG 0.05
  • Stochastic Oscillator
  • HSDT 24.18
  • SNTG 24.42

About HSDT Helius Medical Technologies Inc. (DE)

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.

About SNTG Sentage Holdings Inc.

Sentage Holdings Inc is a financial service provider that offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.

Share on Social Networks: